Skip to main content
SpringerLink
Log in
Book cover

Atherosclerosis Drug Discovery

  • Book
  • © 1976

Overview

Editors:
  1. Charles E. Day

    1. Atherosclerosis Research, The Upjohn Company, Kalamazoo, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 67)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (27 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Primate Models

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. A Model for Therapeutic Interventions on Established Coronary Atherosclerosis in a Nonhuman Primate

      • M. R. Malinow, Phyllis McLaughlin, Lynne Papworth, H. K. Naito, Lena Lewis, W. P. McNulty
      Pages 3-31

    3. The Nonhuman Primates as Models for Studying Human Atherosclerosis: Studies on the Chimpanzee, the Baboon and the Rhesus Macacus

      • V. Blaton, H. Peeters
      Pages 33-64

    4. Phylogenetic Variability of Serum Lipids and Lipoproteins in Nonhuman Primates Fed Diets with Different Contents of Dietary Cholesterol

      • S. R. Srinivasan, C. C. Smith, B. Radhakrishnamurthy, R. H. Wolf, G. S. Berenson
      Pages 65-75

    5. The Baboon in Atherosclerosis Research: Comparison with Other Species and Use in Testing Drugs Affecting Lipid Metabolism

      • A. N. Howard
      Pages 77-87

    6. The Fine Structure of Nonatherosclerotic Intimal Thickening, of Developing, and of Regressing Atherosclerotic Lesions at the Bifurcation of the Left Coronary Artery

      • Herbert C. Stary, Jack P. Strong
      Pages 89-108

    7. Apo-Lipoprotein Localization in Human Atherosclerotic Arteries

      • H. F. Hoff, R. L. Jackson, A. M. Gotto Jr.
      Pages 109-120

  3. Rabbit Models

    1. Front Matter

      Pages 121-121
      Download chapter PDF

    2. Rabbits as a Model for the Study of Hyperlipoproteinemia and Atherosclerosis

      • B. Shore, V. Shore
      Pages 123-141

    3. Seasonal Variations in Severity of Experimental Atherosclerosis in Rabbits

      • David Kritchevsky, Shirley A. Tepper, Jon A. Story
      Pages 143-147

    4. Study of Drugs Affecting Cholesterol-Induced Atherosclerosis in Rabbits

      • Y. S. Kwak, K. T. Lee, D. N. Kim
      Pages 149-167

    5. Turnover and Aortic Uptake of Very Low Density Lipoproteins (VLDL) from Hypercholesteremic Rabbits as a Model for Testing Antiatherosclerotic Compounds

      • J. Rodriguez, A. Catapano, G. C. Ghiselli, C. R. Sirtori
      Pages 169-189

    6. Evaluation of the Permeability Parameters (Influx, Efflux and Volume of Distribution) of Arterial Wall for LDL and Other Proteins

      • S. Ghosh, J. N. Finkelstein, D. B. Moss, J. S. Schweppe
      Pages 191-204

    7. Oxygen Diffusion and Atherosclerosis

      • Joseph D. Pool, John L. Gainer, Guy M. Chisolm III
      Pages 205-211

  4. Rodent Models

    1. Front Matter

      Pages 213-213
      Download chapter PDF

    2. High Volume Screening Procedures for Hypobetalipoproteinemic Activity in Rats

      • Paul E. Schurr, John R. Schultz, Charles E. Day
      Pages 215-229

    3. Biological Activity of a Hypobetalipoproteinemic Agent

      • Charles E. Day, Paul E. Schurr, William E. Heyd, Daniel Lednicer
      Pages 231-249

    4. Nonisotopic Method for Estimating Cholesterogenesis in the Rat

      • W. A. Phillips, J. M. Ratchford, J. R. Schultz
      Pages 251-265

    5. Cholesterol Metabolism in Rats Sensitive to High Cholesterol Diet

      • Nozomu Takeuchi, Masami Ito, Yuichi Yamamura
      Pages 267-288
Back to top

Keywords

About this book

Although atherosclerosis is the leading cause of death in the so-called affluent societies, there is presently no drug in our pharmacologic armamentarium against disease to either prevent or reverse this insidious killer and debilitant of human lives. Because of this void the First Brook Lodge Symposium on Anti­ Atherosclerosis Drug Discovery was convened at Brook Lodge in Augusta, Michigan, August 13-15, 1975. The symposium was sponsored by The Upjohn Company and was international in scope, with investi­ gators attending from such countries as England, Japan, Belgium, and Italy. The symposium focused on the problems associated with the discovery and evaluation of new drugs effective in preventing or reversing atherosclerosis. The thrust of material is centered around animal models useful as tools in the search and evaluation of new drugs. Broadly categorized, the models are nonhuman primates, rabbits, rodents, quail, and tissue culture. The material is a mix of studies on serum lipids and, more importantly, of studies on the artery, irrespective of serum lipid levels. The prevention of arterial lesions, not reduction of serum lipids, is emphasized. A review of all anti-atherosclerotic agents, with the exception of hypolipidemic agents, is included in this volume of the proceedings of the symposium.

Editors and Affiliations

  • Atherosclerosis Research, The Upjohn Company, Kalamazoo, USA

    Charles E. Day

Bibliographic Information

  • Book Title: Atherosclerosis Drug Discovery

  • Editors: Charles E. Day

  • Series Title: Advances in Experimental Medicine and Biology

  • DOI: https://doi.org/10.1007/978-1-4614-4618-7

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 1976

  • Softcover ISBN: 978-1-4757-9309-3Published: 02 June 2013

  • eBook ISBN: 978-1-4614-4618-7Published: 22 November 2013

  • Series ISSN: 0065-2598

  • Series E-ISSN: 2214-8019

  • Edition Number: 1

  • Number of Pages: X, 467

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation